+0.0151  (+0.82%)
Volume (24h): 892.73K Day Range: 1.81 - 1.93
Market Cap: 159.76M 52W Range: 0.3500 - 4.77
Apr-01-20 09:50PM Agile Therapeutics (AGRX) Flat As Market Sinks: What You Should KnowZacks
Mar-23-20 08:31PM Agile Therapeutics (AGRX) Stock Remains a Top Pick, Says AnalystTipRanks
Mar-18-20 12:49PM Implied Volatility Surging for Agile Therapeutics (AGRX) Stock OptionsZacks
Mar-15-20 08:02PM Weekly CFO Buys
Mar-03-20 08:00PM 7 Cheap Stocks Under $7 With Massive Upside PotentialKiplinger
Feb-25-20 04:41PM Agile Therapeutics, Inc. (Nasdaq: AGRX) to Ring Nasdaq Stock Market Closing Bell on Wednesday, February 26, 2020GlobeNewswire
Feb-21-20 05:00PM Agile Therapeutics (AGRX) Upgraded to Buy: Here's WhyZacks
04:30PM Is Agile Therapeutics (AGRX) Stock Outpacing Its Medical Peers This Year?Zacks
Feb-21-20 01:35PM Agile Therapeutics Announces Pricing of $45 Million Underwritten Public Offering of Common StockGlobeNewswire
12:46PM The Daily Biotech Pulse: FDA Approves Baudax Bio's Non-Opioid Pain Drug, Aerie Rallies On Q4 Results, D-Day For EsperionBenzinga
Feb-20-20 09:14PM Agile Therapeutics Announces Proposed Underwritten Public Offering of Common StockGlobeNewswire
09:01PM Agile Therapeutics Reports Fourth Quarter and Full Year 2019 Financial ResultsGlobeNewswire
Feb-14-20 11:46PM FDA Approves Agile Therapeutics, Inc.’s Twirla® (levonorgestrel and ethinyl estradiol) Transdermal System – A New Weekly Contraceptive Patch Delivering a 30 mcg Daily Dose of Estrogen and 120 mcg Daily Dose of ProgestinGlobeNewswire
Feb-12-20 02:18PM The Daily Biotech Pulse: J&J Intensifies Efforts On COVID-19 Cure, Adamas Reports Positive, Long-Term Gocovri DataBenzinga
Feb-11-20 01:46PM Agile Finalizes $35M Term Loan Facility As Twirla PDUFA Date LoomsBenzinga
Feb-10-20 09:30PM Agile Therapeutics, Inc. Enters into up to $35 Million Loan Facility with Perceptive AdvisorsGlobeNewswire
Feb-03-20 06:30PM Attention Biotech Investors: Mark Your Calendar For These February PDUFA DatesBenzinga
Jan-28-20 06:48PM 5 'Strong Buy' Biotech Stocks With Rapidly Approaching CatalystsKiplinger
Jan-10-20 02:33PM The Zacks Analyst Blog Highlights: Agile Therapeutics, Air Industries, Dermira, Microbot Medical and Cassava SciencesZacks
Jan-09-20 11:19AM Buy Multibagger Stocks as Odds of a Rally Are High in 2020Zacks
Jan-06-20 01:00PM Agile Therapeutics to Present at the 38th Annual J.P. Morgan Healthcare Conference in San FranciscoGlobeNewswire
12:35PM Here's How to Play Stocks as US-Iran Tensions MountZacks
Jan-03-20 12:55PM The Daily Biotech Pulse: Acorda Surges As Point72 Hikes Stake, Novan Sinks On Failed Study, Illumina-Pac Bio Terminate MergerBenzinga
Jan-02-20 01:00PM Agile Therapeutics Strengthens Commercial Leadership TeamGlobeNewswire
Dec-23-19 01:36PM Implied Volatility Surging for Agile Therapeutics (AGRX) Stock OptionsZacks
Dec-19-19 09:05PM Agile Therapeutics to Present at Biotech Showcase™ 2020 in San FranciscoGlobeNewswire
Dec-14-19 11:59PM Hedge Funds Have Never Been More Bullish On Agile Therapeutics Inc (AGRX)Insider Monkey
Nov-14-19 09:30PM Agile Therapeutics Announces FDA Extension of Twirla® NDA Review PeriodGlobeNewswire
Nov-11-19 09:40PM RBC: 3 Stock Picks Set to Soar 30%+TipRanks
Nov-05-19 11:53AM The Daily Biotech Pulse: FDA Nod For Sanofi, BioCryst's Edema Drug In Japan, Myriad's Q1 DisappointmentBenzinga
Nov-04-19 04:24PM Agile (AGRX) Stock Surges Over 370%, What’s Next?TipRanks
Oct-31-19 05:11PM Agile Therapeutics' stock rockets nearly 4-fold after contraceptive patch Twirla gets favorable FDA committee nodMarketWatch
02:52PM Agile Therapeutics Rallies After FDA Panel Backs Contraceptive PatchBenzinga
Oct-31-19 12:34PM Benzinga Pro's Top 5 Stocks To Watch For Thurs., Oct. 31, 2019: AAPL, FB, AGRX, X, CROXBenzinga
Oct-30-19 10:33PM Agile Therapeutics Announces Favorable Outcome of FDA Advisory Committee Meeting for its Investigational Transdermal Contraceptive Patch, Twirla® (AG200-15)GlobeNewswire
Oct-29-19 09:24PM Agile (AGRX): Should You Catch this Falling Knife?TipRanks
11:32AM The Daily Biotech Pulse: Mirati Tastes Success With KRAS Inhibitor, Roche-Spark Deal Delayed Further, Morphosys Halts StudyBenzinga
Oct-28-19 12:00PM Agile Therapeutics Reports Third Quarter 2019 Financial ResultsGlobeNewswire
Oct-25-19 01:30PM Is Agile Therapeutics (AGRX) Outperforming Other Medical Stocks This Year?Zacks
01:00PM Agile Therapeutics (AGRX) Upgraded to Buy: Here's What You Should KnowZacks
Oct-24-19 07:57PM 5 'Strong Buy' Biotech Stocks With Rapidly Approaching CatalystsKiplinger
Oct-14-19 04:17AM 3 Top Biotech Stocks With Major Catalysts in OctoberTipRanks
Oct-01-19 01:44PM The Zacks Analyst Blog Highlights: Barrett Business Services, Hibbett Sports, Construction Partners, Agile Therapeutics and Boot BarnZacks
03:16AM Penny Stocks to Buy Using Technical Analysis for October 2019Investopedia
Sep-30-19 12:05PM Trade Worries Resurface! Buy These 5 U.S. Stocks NowZacks
Sep-25-19 12:23PM Top Ranked Momentum Stocks to Buy for September 25thZacks
Sep-19-19 02:29PM Zynerba Releases Data on Epilepsy Candidate, Stock DownZacks
Sep-10-19 01:00PM Agile Therapeutics (AGRX) Upgraded to Strong Buy: Here's What You Should KnowZacks
Sep-06-19 11:30AM Agile Therapeutics to Present at Upcoming Investor ConferencesGlobeNewswire
Sep-05-19 02:12PM 3 “Strong Buy” Biotech Stocks Ahead of FDA VerdictsSmarterAnalyst
Agile Therapeutics, Inc., a women's healthcare company, focuses on the development and commercialization of prescription contraceptive products for women. Its lead product candidate is Twirla, also known as AG200-15, a once-weekly prescription combination hormonal contraceptive patch, which completed Phase III clinical trials. The company is also developing a pipeline of other transdermal contraceptive products, including AG200-ER, a regimen that allows a woman to extend the length of her cycle; AG200-SP, which is a regimen designed to provide shorter lighter periods; AG200-ER (SmP), a regimen to allow a woman to extend the length of her cycle, as well as experience shorter and lighter periods; and AG890, a progestin-only contraceptive patch intended for use by women who are unable or unwilling to take estrogen. Agile Therapeutics, Inc. was founded in 1997 and is headquartered in Princeton, New Jersey.
Stocks in other countries: United Kingdom India Canada Australia
Market Cap
Volume (24h)